Suchergebnisse - "Wang, Hankang"

PubPharm (7)

1

Author Correction : Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma

enthalten in: Scientific reports | 2024

von Wang, H. | Gao, C. | Li, X. | +2

ErratumFor: Sci Rep. 2024 Mar 26;14(1):7140. - PMID 38532022

2

Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma

enthalten in: Scientific reports | 2024

von Wang, H. | Gao, C. | Li, X. | +2

ErratumIn: Sci Rep. 2024 Apr 16;14(1):8787. - PMID 38627555

3

Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma

enthalten in: Oncology reports | 2023

von Sun, L. | Wang, H. | Liu, Q. | +6

4

Iron accumulation and lipid peroxidation : implication of ferroptosis in hepatocellular carcinoma

enthalten in: Frontiers in endocrinology | 2023

von Li, X. | Meng, F. | Wang, H. | +4

5

Experimental study of camptothecin combined with drug-eluting bead transarterial chemoembolization in the rabbit VX2 liver tumor model

enthalten in: Frontiers in oncology | 2022

von Meng, F. | Li, Y. | Liu, Q. | +5

6

Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma : A review

enthalten in: Frontiers in oncology | 2022

von Sun, L. | Xu, X. | Meng, F. | +5

7

Nrf2 Down-Regulation by Camptothecin Favors Inhibiting Invasion, Metastasis and Angiogenesis in Hepatocellular Carcinoma

enthalten in: Frontiers in oncology | 2021

von Liu, Q. | Zhao, S. | Meng, F. | +5

1
[1]